StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by Mermer2328on Oct 28, 2020 9:41pm

116 Views

Post# 31800798

RE:RE:RE:Share price expectations in coming weeks.

With all due respect SAG. I'm still waiting for a response about you're half million per day calculation. Now You throw out more #, like 2 dollars a share. When you're wrong time after time or dont show how you get to these figures, You're no longer credible. That's exactly what Tripp did and that's why the SP is stagnant now. I admire you're enthusiastic tho. good luck!

Bullboard Posts

Canadian government to fund Electric Royalties portfolio property